ArticleJournal of translational medicine2025

Lipidomics reveals biomarkers of the efficacy of first-line ICI therapy combined with chemotherapy in NSCLC.

Jia Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.